Aquestive shareholders elect two Class I directors, approve say-on-pay, ratify KPMG at 2025 annual meeting

Aquestive Therapeutics, Inc.

Daniel Barber and Timothy E. Morris elected as Class I directors with 36,060,882 and 35,562,599 votes for, respectively.
Non-binding advisory vote on executive compensation approved: 32,454,278 for, 6,694,084 against, 459,188 abstain.
Ratification of KPMG as independent auditor for FY 2025 passed: 66,530,646 for, 1,166,766 against.
Broker non-votes of 29,848,112 on director elections and say-on-pay proposal.
Annual Meeting held June 11, 2025; results reported under Item 5.07.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.